Evaluation of Commercial Slides for Detection of Immunoglobulin G against
Four commercial slides were compared with in-house slides for the detection of immunoglobulin G (IgG) against Bartonella henselae in 58 healthy persons from a rural region by an indirect immunofluorescence assay. MRL-BA slides (MRL Diagnostics, USA) and Virion slides (Virion, Switzerland) with agar-derived Bartonella henselae showed IgG titers of >_ 1:256 in 44.8% and 51.7%, respectively, whereas Bion slides (Bios, Germany), MRL-Vero slides (MRL Diagnostics), and in-house slides with cell-associated Bartonella henselae showed such titers in 3.4%, 5.1% and 3.4%, respectively. The MRLVero slides (Bartonella IgG substrate slides, MRL Diagnostics) were further evaluated with 26 patients with cat scratch disease, 20 patients with lymphadenopathy not due to cat scratch disease, 100 blood donors from an urban area, and 120 blood donors from a mixed urban/rural area. In our mixed urban/rural population the IgG titer of 1:256 had a sensitivity of 84.6% and a specificity of 93.4% for the serodiagnosis of cat scratch disease. Seroprevalence was higher in blood donors from the mixed area (50.8%) than from the urban area (37%). MRL-Vero slides were considered useful for the serodiagnosis of cat scratch disease by indirect immunofluorescence and have replaced our in-house system. However, patients with low IgG titers should be retested three to four weeks after initial sampling to demonstrate a possible rise of IgG titers in paired sera.
Cat scratch disease (CSD) has traditionally been diagnosed in patients with regional lymphadenopathy if three of the following criteria are met: contact with a cat and the presence of a scratch or a primary lesion; negative studies for other possible causes of lymphadenopathy; a positive skin test; and characteristic histopathological findings (1) . By means of culture and the polymerase chain reaction (PCR), Bartonella henselae has been recently recognized as the major causative agent of CSD (2, 3) . The CSD skin test has been shown to have a lower sensitivity than PCR for Bartonella henselae and may, for this and for safety reasons, have lost its usefulness (4). Histopathological analyses are only possible following surgical biopsy. Serology has made important contributions to recognition of the causative agent (5), epidemio-logical studies (6) , and a better delineation of the clinical spectrum of CSD (7) . Thus, serology may become the simplest and most feasible way to diagnose CSD, provided the tests are reliable (8) .
We recently demonstrated the intracellular location of Bartonella henselae after cocultivation with Vero cells. Fixed slides with monolayers of Vero cells with intracellular Bartonella henselae were used in an indirect immunofluorescence assay (IFA) for detecting immunoglobulin G (IgG) to Bartonella henselae (9) . The workload associated with cocultivation of Bartonella henselae with Vero cells on chamber slides for the inhouse IFA was considered reasonable as long as no alternatives were available. In the meantime, several commercial slides for IFA have been developed for the detection of IgG to Bartonella henselae. In the present study we compared our inhouse IFA with four commercial IFAs. Furthermore, we determined the diagnostic value of one commercial IFA with Vero cell-associated Bartonella henselae. Statistical Calculations. The optimal cut-off for the commercial Vero cell-associated IFA evaluated was chosen according to the balance desired between sensitivity and specificity (11) .
Results
The comparison of commercial with in-house slides for the determination of IgG titers to Bartonella henselae by IFA is shown in Table 1 . Among the 58 individuals from the rural region, titers of _> 1:256 were detected with the agarderived MRL-BA and Virion slides in 26 (44.8%) and 30 (51.7%) sera and titers of < 1:64 in six (10.3%) and seven (12%) sera, respectively. In contrast, when employing Bion, MRL-Vero, and in-house slides with cell-associated Bartonella henselae, titers of _> 1:256 were found in two (3.4%), three (5.1%), and two (3.4%) sera and titors of < 1:64 in 20 (34.5%), 25 (43.1%), and 24 (41.5%) sera, respectively. With Bion slides 97% of the titers were within one log 2 dilution of the corresponding titers obtained with the in-house system; with MRL-Vero slides all titers were within one log 2 dilution and 72.4% were identical to those of the in-house system. However, with the two commercial slides with agar-derived Bartonella henselae, 60.3% of all sera had titer differences of two or more log 2 dilutions compared to titers obtained with the in-house IFA.
Thirty-three of the 58 individuals were cat owners. Using any slides with cell-associated Bartonella henselae, cat owners more frequently had titers of > 1:64 than persons without cats (p < 0.05, Table 2 ). The slides with blood agar-derived Bartonella henselae showed in only one patient a fourfold titer rise in paired sera and a higher titer than the corresponding median titer of cat owners. The Bion and MRL-Vero slides showed higher titers than the median titers of cat owners in all four patients.
The diagnostic value of the commercial Vero cellassociated MRL slides was further evaluated. Table 3 shows the IgG titers of 26 patients (including the first sera of the 4 patients from Table 2 ) with CSD and controls. All control patients with lymphadenopathy without suspected CSD had titers of < 1:64, except one who had a titer of 1:128. Fourteen of 220 blood donors had titers of 1:256 and one a titer of 1:512. Blood donors from the mixed urban/rural area more frequently had IgG titers (50.8%) than blood donors from the urban area (37%) (p < 0.05, Fisher's exact test). For the serodiagnosis of CSD in our mixed urban/rural population, the IgG titer of 1:256 had a sensitivity of 84.6% and a specificity of 93.4%.
Discussion
In the present comparison of commercial IFA slides, those containing cell-associated Bartonella henselae revealed lower IgG titers than slides containing blood agar-derived bacilli. Four patients included in this comparison had IgG titers to Bartonella henselae similar to those of the normal rural population when the agar-derived slides were used. We therefore excluded these slides from consideration for replacement of our inhouse system. The Vero cell-associated MRL slides showed in 72% the same titer as the inhouse slides and were further evaluated for detection of IgG to Bartonella henselae.
Sera from patients with and without CSD and from blood donors from two different geograph- Table 3 " Immunoglobulin G titers to Bartonella henselae of patients with cat scratch disease (CSD), control patients, urban blood donors, and mixed urban/rural blood donors using the MRL-Vero slides. When a titer of 1:512 is used as the cut-off, sensitivity is 61.5% and specificity 99.6%; with 1:256 as the cut-off, sensitivity is 84.6% and specificity 93.4%; with 1:128 as the cut-off, sensitivity is 100% and specificity 83.4%. ical regions were included in this evaluation. To achieve a specificity of over 90%, the titer of 1:256 was chosen as the cut-off. The titer of 1:128 would have had a specificity below 85 % but a sensitivity of 100%. Others have found that a cut-off titer of 1:100 with a cell-associated system is not sensitive enough (40.6%) to confirm a CSD diagnosis; the low sensitivity was attributed to blood sampling before an antibody increase had occurred (12) . However, the positive predictive value of a titer of 1:100 with the same IFA was only 68.2% (13) . A cell-associated IFA with the new Bartonella henselae serovariant "Marseille" revealed in three of 100 healthy blood donors a titer of 1:200, which was considered the cut-off titer (14) . In a previous study, 11 patients with a Bartonella henselae infection (proven by PCR or characteristic histopathological findings) had titers of 1:256 or higher with the in-house IFA (15) . In a further study with the in-house system, titers of 1:512 or higher were found in 20 of 20 children presenting with subacute lymphadenopathy and a history of recent cat scratch (10) . In three of these CSD patients, the initial titers were only 1:128 and 1:256, but within three weeks a rise to 1:1024 was noted. By contrast, in only one of the 332 controls (including 43 persons from households of the patients) was a titer of 1:512 found (10).
Our most important observation was the difference in IgG titers obtained with the various commercial slides, depending on the antigen preparation. It was recently shown in one patient that titers to Bartonella henselae differed greatly, depending on the antigen preparation for the IFA: the patient had a titer of 1:12,800 against a sheep blood agar strain and a titer of 1:200 against the same strain cultivated on endothelial cells (14) . A similar discrepancy was described for IgG antibodies against Bartonella quintana grown on sheep blood agar and human epithelial cells (16) .The first IFA to detect IgG to Bartonella henselae was based on cocultivation with Vero cells to inhibit autoagglutination of Bartonella henselae (5) . The present study showed that cocultivation improves the specific detection of IgG to Bartonella henselae. The reasons for this are unknown, but antigenic proteins could perhaps change during cocultivation. Such changes are suggested during phase variation (17) . The intracellular location of Bartonella henselae in the two commercial cell-associated slides (MRL-Vero and Bion) can be assumed because the specific fluorescence had the same granular aspect as shown previously with our in-house slides (9) .
Besides the antigen preparation of Bartonella henselae, epidemiological parameters affect the serodiagnosis of Bartonella henselae infection (18) . In all IFA systems serum samples of people reporting cat contact had higher titers than sera of persons without cat contact. In line with our previous study of the in-house system (10), we also found by means of the MRL-Vero slides a higher seroprevalence in blood donors from the mixed urban/rural population than in those from the city. This could be explained by close cat contact in rural regions. Low IgG titers could relate to unapparent or past infection with Bartonella henselae. Finally, serodiagnosis can be influenced by cross-reacting antibodies against other bacterial antigens, e.g., Bartonella with Coxiella (19) and other ~-2 protobacteria (20) .
We conclude that, using the MRL-Vero slides, a titer of 1:256 is compatible with CSD in our mixed urban/rural population. For routine purposes, the MRL-Vero slides can replace our inhouse system. Until tests to detect IgM to Bartonella henselae have been thoroughly evaluated, patients with clinical signs and symptoms of CSD plus low specific IgG titers should have paired sera drawn in intervals of three to four weeks in order to detect a possibly significant antibody rise. We believe that serology may replace traditional diagnostic criteria for CSD (8, 10) , but histology and PCR may still be necessary in atypical clinical situations.
